Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men

被引:6
作者
Yeh, Chin-Bin [2 ]
Chou, Yuan-Hwa [3 ,4 ]
Cheng, Cheng-Yi [1 ]
Lee, Meei-Shyuan [5 ]
Wang, Jhi-Joung [6 ]
Lee, Chiang-Hsuan [6 ]
Shiue, Chyng-Yann [1 ]
Su, Tung-Ping [3 ,4 ]
Huang, Wen-Sheng [1 ,7 ]
机构
[1] Triserv Gen Hosp, Dept Nucl Med, Taipei 114, Taiwan
[2] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[4] Natl Yang Ming Univ, Taipei 112, Taiwan
[5] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan
[6] Chi Mei Med Ctr, Dept Nucl Med, Tainan, Taiwan
[7] Cardinal Tien Hosp, Dept Nucl Med, Taipei, Taiwan
关键词
Reproducibility; Dopamine transporter; Tc-99m-TRODAT-1; POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE; TC-99M-TRODAT-1; SPECT; CLINICAL-DIAGNOSIS;
D O I
10.1016/j.pscychresns.2011.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Single photon emission computed tomography (SPECT) with Tc-99m TRODAT-1 as ligand can be used to evaluate striatal dopamine transporters (DAT) in young subjects. The purpose of this study was to evaluate the reproducibility of Tc-99m-TRODAT-1 SPECT in DAT binding in healthy young men. Fourteen healthy young men were recruited. The test-retest studies were performed 1 week apart. Specific uptake ratios (SUR) of the striatum (ST) and its subregions, the caudate (CA) and the putamen (PU), were measured using the occipital cortex as the reference tissue. The reliability of the two measurements between test and retest, showed significant correlations for the ST. CA and PU, was demonstrated by calculating the intraclass correlation coefficient (ICC). Thus, Tc-99m-TRODAT-1 SPECT might provide a reproducible and reliable tool in clinical management of young patients with DAT-related disorders. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:222 / 225
页数:4
相关论文
共 34 条
  • [1] The dopamine transporter: role in neurotoxicity and human disease
    Bannon, MJ
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) : 355 - 360
  • [2] Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography
    Bao, SY
    Wu, JC
    Luo, WF
    Fang, P
    Liu, ZL
    Tang, J
    [J]. JOURNAL OF NEUROIMAGING, 2000, 10 (04) : 200 - 203
  • [3] Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism
    Booij, J
    Tissingh, G
    Winogrodzka, A
    van Royen, EA
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (02) : 171 - 182
  • [4] Booij J, 1998, J NUCL MED, V39, P1879
  • [5] Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study
    Chou, Yuan-Hwa
    Huang, Wen-Sheng
    Su, Tung-Ping
    Lu, Ru-Band
    Wan, Fang-Jung
    Fu, Ying-Kay
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (01) : 46 - 52
  • [6] Imaging the serotonin transporter using 123I-ADAM in the human brain
    Chou, Yuan-Hwa
    Yang, Bang-Hung
    Chung, Ming Yi
    Chen, Shih-Pei
    Su, Tung-Ping
    Chen, Chia-Chieh
    Wang, Shyh-Jen
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2009, 172 (01) : 38 - 43
  • [7] Dresel SHJ, 1998, EUR J NUCL MED, V25, P31
  • [8] Fischman AJ, 1997, J NUCL MED, V38, P144
  • [9] Diagnostic criteria for Parkinson disease
    Gelb, DJ
    Oliver, E
    Gilman, S
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (01) : 33 - 39
  • [10] Huang WS, 2001, J NUCL MED, V42, P1303